Tara P. B.
- Country
- Spain
- Department
- Pneumology Department
Research Overview
- Evaluation of Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Patients
- Phase 2 Double-Blind Study of SAR447537 vs. Plasma-Derived Alpha1-Proteinase Inhibitor in Adults with Alpha-1 Antitrypsin Deficiency Emphysema
- Evaluation of Long-Term Safety and Efficacy of SAR447537 in Adults with Alpha-1 Antitrypsin Deficiency Emphysema
Data & Insights
Has run more than one trial at 9 of 245 partner sites.
Specializations
Respiratory Diseases
This investigator specializes in treating complex respiratory conditions, with particular emphasis on Alpha-1 Antitrypsin Deficiency (AATD) Emphysema and Chronic Obstructive Pulmonary Disease (COPD).
- AATD-related emphysema management
- COPD treatment optimization
- Respiratory function assessment
The investigator's work focuses on evaluating innovative therapeutic approaches for genetic and acquired respiratory disorders.
Therapeutic Innovation
The investigator explores advanced treatment modalities, including combination inhaler therapies and protein replacement approaches for respiratory conditions.
- Novel therapeutic compounds
- Bronchodilator combinations
- Protein replacement therapy
Their research encompasses both established and emerging therapeutic options for chronic respiratory diseases.
Clinical Outcomes
The investigator's work centers on evaluating cardiopulmonary outcomes and long-term safety profiles of respiratory treatments.
- Treatment efficacy assessment
- Long-term safety monitoring
- Therapeutic response evaluation
Their research aims to advance understanding of treatment effectiveness in chronic respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.